MHRA alert Archives | Dispensing Doctors' Association

March 12th 2025

Alert: azithromycin 250 mg capsules

Jubilant Pharmaceuticals NV has issued an alert for 11 batches of azithromycin 250 mg capsules due to an out of date PIL. Faulty PILs are dated as revised in October 2021, and do not feature the ‘What you need to know before you take’ in

March 4th 2025

Alert: Accord azacitidine powder for suspension

Accord Healthcare Limited is recalling certain batches of azacitidine powder for suspension for injection 100 mg/vial and 150 mg/vial as precautionary measure due to out of specification results for azacitidine related compound C impurity during stab

February 24th 2025

Alert: PI glucophage SR

Batches of PI glucophage SR 500 mg, 750mg and 1000mg prolonged-release tablets are being recalled as a precautionary measure due to the product being manufactured with the incorrect grade of an excipient. The hydroxypropyl methylcellulose used in the

Hot topics

DM Zone news HR Zone news Clinical guidance news Political News Scotland Wales Rurality Supply Shortages COVID19

February 12th 2025

Alert: Teva lansoprazole GR 15mg capsules

Teva UK Limited has advised of a typographical error affecting 12 batches of lansoprazole gastro-resistant hard capsules 15mg. On affected batches, the dosage form is stated as “tablets” where it should state “gastro-resistant capsu

February 6th 2025

Alert: Nitrofurantoin 100 mg Prolonged-Release capsules

Two batches of CNX Therapeutics Nitrofurantoin 100 mg Prolonged-Release capsules are being recalled due to the presence of additional tablets. The affected batches are: Batch Number Expiry Date Pack Size First Distribu

January 31st 2025

Alert: amlodipine Bristol Lab 2.5mg tablets

Bristol Laboratories Limited is recalling four batches of amlodipine Bristol Lab 2.5mg tablets as a precautionary measure due to possible microbial contamination. The affected batches are: Batch Number Expiry Date Pack Size Firs

January 14th 2025

Alert: irbesartan 150 mg and 300 mg film-coated tablets

Some 16 batches of Jubilant Pharmaceuticals irbesartan 150 mg and 300 mg film-coated tablets are the subject of an alert relating to missing safety information in the PILs (warnings and precautions and possible side effects). Affected packs co